Retatrutide Done Right? Why Weekly Dosing Causes Spikes (And Daily Fixes It)

Most retatrutide side effects aren’t from the compound they’re from how it’s dosed.
In this video, I explain why weekly retatrutide dosing creates spikes, fatigue, and sleep issues and why daily microdosing creates control instead.

Retatrutide is a triple-agonist GLP-1 research compound that targets GLP-1, GIP, and the glucagon receptor.
That glucagon activity is powerful but only when it’s controlled.

Weekly dosing creates metabolic peaks and crashes.
Daily microdosing smooths the signal.

In this video, I break down:
• Why GLP-1s are supposed to feel “boring”
• Why weekly dosing causes spikes, crashes, and fatigue
• How glucagon changes retatrutide dosing logic
• Why daily microdosing works better specifically for retatrutide
• Why morning dosing matters
• The biggest mistake people make when switching to daily dosing
• How to know if your dose is still too high

This video is for educational and research discussion purposes only.

👇 Comment below:
Are you dosing weekly or daily and how does it feel?

00:00 GLP-1s Are Supposed to Be Boring
00:30 The Real Retatrutide Problem
01:20 Why People Think Retatrutide “Failed”
02:00 Weekly Dosing Creates Spikes
03:00 Stress Cycling vs Metabolic Control
03:45 Why Not Feeling It Doesn’t Mean It’s Not Working
04:00 What Daily Microdosing Changes
04:30 Control vs Spike (Signal Smoothing)
05:00 Why Retatrutide Is Different (Glucagon)
05:40 Weekly Glucagon Peaks Explained
06:20 Daily Glucagon Control
06:55 Why Morning Dosing Matters
07:40 Appetite Control Becomes Passive
08:25 The Biggest Daily Dosing Mistake
09:20 How to Know Your Dose Is Too High
10:00 Final Takeaway

#Retatrutide
#GLP1
#GLP1Agonist
#GLP1WeightLoss
#Microdosing
#FatLoss
#Peptides
#ResearchPeptides
#WeightLossScience